Traditional processor architectures are failing to keep up with the exploding compute demands of AI workloads. They are limited by the power-hungry weight-fetch of von Neumann architectures and limitations of transistor and frequency scaling. At-memory computation places compute elements directly next to the memory array, providing reduced power consumption and increased throughput due to the massive parallelism and memory bandwidth provided by the architecture.

Founded in 2010, Paul Dick & Associates (PDA) is a Canadian consulting company specializing in the creation of outstanding product development, regulatory and commercial value for the animal and human health industries. Our highly experienced team uses innovative, best in class business, R&D and regulatory strategies that are creative, efficient and effective for our customers.

Regulatory Guidance for Animal Health Start-Ups – Presented by Dr. Klaus Hellmann, CEO of KLIFOVET AG

20 minutes panel discussion: Advice for Innovators Seeking Strategic Growth and Investment with 20 minutes Q&A

Founded in 2010, Paul Dick & Associates (PDA) is a Canadian consulting company specializing in the creation of outstanding product development, regulatory and commercial value for the animal and human health industries. Our highly experienced team uses innovative, best in class business, R&D and regulatory strategies that are creative, efficient and effective for our customers.

Join industry leaders in discussion on the standardisation of vein-to-vein processes to ensure that digital technologies stay in line with the clinical science that is driving the progression of the field.

Speakers:

Steven Feldman - Stanford University
Frank Thielman - Takeda
Mark Benmoise - Skills Alliance
Seshu Tyagarajan - Novartis Pharmaceuticals Corporation

Key questions addressed:

To review what the impact of the latest oncological data shared at ASH will be, Swapnika Ramu, Scientific Editor, Cell Press will be hosting a free-to-attend panel discussion on December 15th, 2020. Tune in to:

This panel will explore current missing essential components in petfood and key learnings from the human milk oligosaccharide (HMO) breakthrough innovation in human infant and adult nutrition. The panel will highlight the need for natural, intelligent, scientifically proven microbiome solutions, tailored specifically for companion animals. This the HMO to AMO (animal milk oligosaccharide) story, exploring nature’s solution for parents and now pet parents.